Nomura Holdings Inc Dexcom Inc Call Options Transaction History

Nomura Holdings Inc

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $31.8 Million - $40.5 Million	-288,500 Reduced 94.28%	17,500 $1.98 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $35 Million - $42.9 Million	306,000 New	306,000 $42.4 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $7.68 Million - $8.95 Million	-68,300 Reduced 49.64%	69,300 $8.91 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $14.3 Million - $16.9 Million	137,600 New	137,600 $16 Million
Q3 2022 Nov 15, 2022	BUY	$76.35 - $94.18 $5.93 Million - $7.32 Million	77,700 Added 195.23%	117,500 $9.46 Million
Q2 2022 Aug 15, 2022	SELL	$67.99 - $132.89 $2.93 Million - $5.73 Million	-43,100 Reduced 51.99%	39,800 $3.09 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $5.44 Million - $6.82 Million	41,900 Added 102.2%	82,900 $44.6 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $3.64 Million - $4.88 Million	34,100 Added 494.2%	41,000 $22.5 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $585,051 - $722,706	6,900 New	6,900 $2.48 Million

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.